FDG PET in oral and oropharyngeal cancer. Value for confirmation of N0 neck and detection of occult metastases
- PMID: 17306603
- DOI: 10.1016/j.oraloncology.2006.12.003
FDG PET in oral and oropharyngeal cancer. Value for confirmation of N0 neck and detection of occult metastases
Abstract
Treatment of the clinical N0 neck in squamous cell carcinoma (SCC) of oral cavity and oropharynx remains a dilemma. None of the current imaging modalities are able to detect the presence of micrometastases in the lymph nodes of clinical N0 necks reliably. The aim of this study was to determine the diagnostic properties of fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) in patients clinically staged as N0. FDG PET results of 38 patients were compared to histologic specimens obtained with neck dissections or to follow-up. FDG PET performance was compared to computed tomography (CT), magnetic resonance imaging (MRI) or ultrasonography-guided fine needle aspiration cytology (USgFNAC). Sensitivity and specificity of FDG PET in detecting occult cervical metastases were 50% and 97% respectively. Although FDG PET performed better than conventional imaging modalities, sensitivity was lower than desired. As a consequence, clinical application of FDG PET in the patient staged as N0 is limited.
Similar articles
-
Positron emission tomography in the evaluation of the negative neck in patients with oral cavity cancer.J Otolaryngol. 1998 Dec;27(6):342-7. J Otolaryngol. 1998. PMID: 9857320
-
Is there a role for positron emission tomography with 18F-fluorodeoxyglucose in the initial staging of nodal negative oral and oropharyngeal squamous cell carcinoma.Head Neck. 2002 Apr;24(4):345-9. doi: 10.1002/hed.10057. Head Neck. 2002. PMID: 11933176
-
Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.J Clin Oncol. 2006 Sep 20;24(27):4371-6. doi: 10.1200/JCO.2006.05.7349. J Clin Oncol. 2006. PMID: 16983105
-
FDG PET/CT for Management and Assessing Outcomes of Squamous Cell Cancer of the Oral Cavity.AJR Am J Roentgenol. 2015 Aug;205(2):W150-61. doi: 10.2214/AJR.14.13830. Epub 2015 May 22. AJR Am J Roentgenol. 2015. PMID: 26001119 Review.
-
The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor.Cancer. 2004 Dec 1;101(11):2641-9. doi: 10.1002/cncr.20687. Cancer. 2004. PMID: 15517576 Review.
Cited by
-
Distant metastases and synchronous malignancies on FDG-PET/CT in patients with head and neck cancer: a retrospective study.Acta Radiol. 2020 Sep;61(9):1196-1204. doi: 10.1177/0284185119896344. Epub 2020 Jan 5. Acta Radiol. 2020. PMID: 31902218 Free PMC article.
-
Multicenter Trial of [18F]fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging of Head and Neck Cancer and Negative Predictive Value and Surgical Impact in the N0 Neck: Results From ACRIN 6685.J Clin Oncol. 2019 Jul 10;37(20):1704-1712. doi: 10.1200/JCO.18.01182. Epub 2019 Feb 15. J Clin Oncol. 2019. PMID: 30768363 Free PMC article. Clinical Trial.
-
The relationship between the uptake of alveolar bone inflammation and of cervical lymph nodes on fluoro-2-deoxy-D-glucose positron emission tomography.Dentomaxillofac Radiol. 2024 Sep 1;53(6):372-381. doi: 10.1093/dmfr/twae019. Dentomaxillofac Radiol. 2024. PMID: 38781496 Free PMC article.
-
Focus issue: neck dissection for oropharyngeal squamous cell carcinoma.ISRN Surg. 2012;2012:547017. doi: 10.5402/2012/547017. Epub 2012 Jan 15. ISRN Surg. 2012. PMID: 22586518 Free PMC article.
-
Clinical significance of SUVmax in (18)F-FDG PET/CT scan for detecting nodal metastases in patients with oral squamous cell carcinoma.Springerplus. 2015 Nov 24;4:718. doi: 10.1186/s40064-015-1521-6. eCollection 2015. Springerplus. 2015. PMID: 26636006 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials